Polymyxin B is a cationic polypeptide antibiotic derived from the bacterium Bacillus polymyxa, widely used to treat serious multidrug-resistant Gram-negative bacterial infections. By disrupting the integrity… Read more
Polymyxin B is a cationic polypeptide antibiotic derived from the bacterium Bacillus polymyxa, widely used to treat serious multidrug-resistant Gram-negative bacterial infections. By disrupting the integrity of the bacterial cell membrane, this bactericidal agent effectively causes cell lysis in pathogens such as Pseudomonas aeruginosa and Acinetobacter baumannii. This category contains high-quality reference standards for Polymyxin B, alongside a comprehensive selection of its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories performing impurity profiling, method validation, and rigorous quality control testing. By providing precise analytical standards, these compounds assist researchers in ensuring accurate identification and quantification of impurities during stability studies and formulation development, facilitating adherence to regulatory standards throughout the pharmaceutical lifecycle.